Trial Profile
A Phase 4 Multicenter, Randomized, Placebo-controlled Study Evaluating the Effect of Apremilast on Pruritus and Quality of Life of Patients With Moderate-to-severe Scalp Psoriasis
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2020
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms APRESCALP
- 19 Jun 2018 New trial record